BioSpace News Archive

Career Advice

Logistical skills: The Panacea The Pharma Sector Needs

With a swirl of rumors around the changes in ownership in the pharma industry, this invariably triggers reviews of business strategies. Because of this, wider skillsets from related sectors are needed.

June 1, 2022
·
4 min read
·
Leigh Anderson
Drug Development

Sage/Biogen Depression Drug Yields Positive Results in Postpartum Depression

Sage Therapeutics and partner Biogen shared news that their phase III Skylark study has yielded promising results for women suffering from severe postpartum depression (PPD).

June 1, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development

Axsome’s Phase III Results Show Significant Improvement in Depression

Axsome Therapeutics published results of its Phase III trial of AXS-05 that demonstrated rapid, substantial and statistically significant improvement in depressive symptoms.

June 1, 2022
·
3 min read
·
Mark Terry
Business

Sanofi, Sobi and Midatech Gain FDA’s Vote of Confidence in Hemophilia, Cancer

The FDA has issued special designations that could improve the lives of millions with recurrent glioblastoma or hemophilia diagnoses.

June 1, 2022
·
3 min read
·
Jazmine Colatriano M.S.
Novel Herpesvirus Research, Vaccines Breaking Ground

There are more than 100 known herpesviruses, eight of which infect only humans. Here’s a look at recent stories and research on herpesviruses.

June 1, 2022
·
5 min read
·
Mark Terry
Business

Gene-Editing the Microbiome: The Limitless Possibilities

Eligo Bioscience has thought of a way to solve the dysbiosis between our bodies and our microbiomes – gene editing. BioSpace spoke with Eligo Co-founder and CEOXavier Duportet, Ph.D.

June 1, 2022
·
5 min read
·
Hayley Shasteen
Hyaluronic Acid Based Dermal Fillers Market Outlook, Opportunity and Demand Analysis, Forecast 2019 - 2027

Albany NY, United States: Patients and dermatologists alike are becoming more interested in hyaluronic acid dermal fillers.

June 1, 2022
·
6 min read
Dermatophytosis Treatment Market Insights [Size | Shares | Trends | Growth] – Global Industry Analysis [2020-2030]

Dermatophytosis is an infectious disease caused by fungi known as dermatophytes.

June 1, 2022
·
8 min read
Drug Development

Abivax Phase 2a Study Results of Obefazimod (ABX464) in Rheumatoid Arthritis Published in the Journal “Annals of the Rheumatic Diseases” and Selected for Presentation at EULAR 2022

Abivax SA announces that a scientific article on its phase 2a clinical study results for the treatment of moderate to severe active rheumatoid arthritis with obefazimod has been published in the renowned peer-reviewed journal “Annals of the Rheumatic Diseases ".

June 1, 2022
·
10 min read
LINDIS Biotech Announces Online Publication of Abstract on Trifunctional Antibody CATUMAXOMAB for the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer at the ASCO 2022 Annual Meeting

LINDIS Biotech GmbH announces the online publication of an abstract presenting interim data from the Company’s Catunibla Phase I dose escalation trial with CATUMAXOMAB at the American Society of Clinical Oncology Annual Meeting.

June 1, 2022
·
7 min read